Helen M. Boudreau - May 24, 2022 Form 4 Insider Report for Rallybio Corp (RLYB)

Role
Director
Signature
By: /s/ Michael Greco, Attorney-in-Fact
Stock symbol
RLYB
Transactions as of
May 24, 2022
Transactions value $
$0
Form type
4
Date filed
5/26/2022, 08:09 PM
Previous filing
Dec 7, 2021
Next filing
Jun 10, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLYB Option (Right to Buy) Award $0 +13.4K $0.00 13.4K May 24, 2022 Common Stock 13.4K $12.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 24, 2023 or the date of the Company's 2023 Annual Meeting of Stockholders.